We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Assessment of Anti-SARS-CoV-2 Antibodies Post-Coronavac Vaccination in the Amazon Region of Brazil.
- Authors
Bichara, Carlos David Araújo; Queiroz, Maria Alice Freitas; da Silva Graça Amoras, Ednelza; Vaz, Gergiane Lopes; Vallinoto, Izaura Maria Vieira Cayres; Bichara, Cléa Nazaré Carneiro; Amaral, Isabella Pinheiro Costa do; Ishak, Ricardo; Vallinoto, Antonio Carlos Rosário
- Abstract
The present study evaluated the frequency of seropositivity for anti-SARS-CoV-2 (S1 and S2) total antibodies and anti-SARS-CoV-2 (receptor binding domain-RBD-S1) neutralizing antibodies in individuals vaccinated with the immunizing agent Coronavac. This was a cross-sectional study involving 358 individuals divided into two groups. Group 1 consisted of 205 volunteers who were tested for anti-SARS-CoV-2 total antibodies; group 2 consisted of 153 individuals tested for the presence of anti-SARS-CoV-2 neutralizing antibodies. Seropositivity was greater than 70% in both groups, although 17.6% and 20.9% of individuals showed no neutralizing or total antibody reactivity, respectively. The frequency of anti-SARS-CoV-2 total antibodies displayed a significantly different distribution between the sexes but not according to age. The frequency of anti-SARS-CoV-2 neutralizing antibodies was 93.3% (95% CI 68.1–99.8) in the age group from 21 to 40 years but significantly decreased with advancing age, and was 76.2% (95% CI 52.8–91.8) for 41 to 60 years, 72.5% (95% CI 62.8–80.9) for 61 to 80 years, and 46.7% (95% CI 21.3–73.4) for >80 years. Our results reveal a high prevalence of anti-SARS-CoV-2 total antibodies and anti-SARS-CoV-2 neutralizing antibodies in individuals who received both doses of the Coronavac vaccine, suggesting a lower effectiveness of the humoral immune response among those older than 60 years of age, which might be associated with senescence of the immune system.
- Subjects
BRAZIL; IMMUNOGLOBULINS; HUMORAL immunity; SEROCONVERSION; VACCINATION; COVID-19 vaccines
- Publication
Vaccines, 2021, Vol 9, Issue 10, p1169
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines9101169